Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • About
  • Communities & Collections
  • Advanced Search
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. School of Public Health
  4. Department of Infectious Diseases
  5. Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
 
  • Details
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
File(s)
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.pdf (1.64 MB)
Published version
Author(s)
Musasia, Fauzia K
Nkumama, Irene N
Frank, Roland
Kipkemboi, Victor
Schneider, Martin
more
Type
Journal Article
Abstract
Ring-infected erythrocytes are the predominant asexual stage in the peripheral circulation but are rarely investigated in the context of acquired immunity against Plasmodium falciparum malaria. Here we compare antibody-dependent phagocytosis of ring-infected parasite cultures in samples from a controlled human malaria infection (CHMI) study (NCT02739763). Protected volunteers did not develop clinical symptoms, maintained parasitaemia below a predefined threshold of 500 parasites/μl and were not treated until the end of the study. Antibody-dependent phagocytosis of both ring-infected and uninfected erythrocytes from parasite cultures was strongly correlated with protection. A surface proteomic analysis revealed the presence of merozoite proteins including erythrocyte binding antigen-175 and -140 on ring-infected and uninfected erythrocytes, providing an additional antibody-mediated protective mechanism for their activity beyond invasion-inhibition. Competition phagocytosis assays support the hypothesis that merozoite antigens are the key mediators of this functional activity. Targeting ring-stage parasites may contribute to the control of parasitaemia and prevention of clinical malaria.
Date Issued
2022-07-14
Date Acceptance
2022-06-27
Citation
Nature Communications, 2022, 13 (1), pp.1-12
URI
http://hdl.handle.net/10044/1/99665
URL
https://www.nature.com/articles/s41467-022-31640-6
DOI
https://www.dx.doi.org/10.1038/s41467-022-31640-6
ISSN
2041-1723
Publisher
Nature Research
Start Page
1
End Page
12
Journal / Book Title
Nature Communications
Volume
13
Issue
1
Copyright Statement
© The Author(s) 2022. This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
http://creativecommons.org/licenses/by/4.0/
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/35835738
PII: 10.1038/s41467-022-31640-6
Subjects
Animals
Antibodies, Protozoan
Antigens, Protozoan
Erythrocytes
Humans
Malaria
Malaria, Falciparum
Merozoites
Parasitemia
Parasites
Phagocytosis
Plasmodium falciparum
Proteomics
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2022-07-14
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback